URBAN ALAN LOUIS
SEC insider (Form 3/4/5 filer). CIK 0001534376. Chief Financial Officer at GT Biopharma, Inc. (GTBP). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 4, 2025.
Companies URBAN ALAN LOUIS has filed insider reports for
- GT Biopharma, Inc. (GTBP): Officer, Chief Financial Officer
URBAN ALAN LOUIS
CIK: 0001534376
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GTBP
GT Biopharma, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 4, 2025GTBP
GT Biopharma, Inc.
AwardDirectOption to purchase Common Stock
50K shares- - Sep 4, 2025GTBP
GT Biopharma, Inc.
AwardDirectOption to purchase Common Stock
50K shares- - Oct 17, 2024GTBP
GT Biopharma, Inc.
AwardDirectOption to purchase Common Stock
23.3K shares-
1-3 of 3 transactions